Pressure BioSciences (Pressure BioSciences) Float Percentage Of Total Shares Outstanding : 89.24% (As of May. 26, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Pressure BioSciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pressure BioSciences's float shares is 22.97 Mil. Pressure BioSciences's total shares outstanding is 25.74 Mil. Pressure BioSciences's float percentage of total shares outstanding is 89.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pressure BioSciences's Insider Ownership is 42.30%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pressure BioSciences's Institutional Ownership is 0.01%.

Pressure BioSciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Pressure BioSciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	22.97	/	25.74
	=	89.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences (Pressure BioSciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pressure BioSciences Inc (OTCPK:PBIO) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

14 Norfolk Avenue, South Easton, MA, USA, 02375

Website

https://www.pressurebiosciences.com

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.

Executives

Daniel Joseph Shea	officer: Senior Vice President & CFO	2 MINUTEMAN ROAD, MEDFIELD MA 02052
Bradford Addison Young	officer: Chief Commercial Officer	513 LITTLE JOHN HILL, ANNAPOLIS MD 21405
Richard T Schumacher	director, officer: Chief Executive Officer	375 WEST STREET, WEST BRIDGEWATER MA 02379
Nathan Lawrence	other: VP Sales and Marketing	321 MANLEY STREET, WEST BRIDGEWATER MA 02379
Richard Thomley	officer: Chief Financial Officer	C/O PRESSURE BIOSCIENCES, INC., 14 NORFOLK AVE., SOUTH EASTON MA 02375
Kevin Pollack	director	150 RAINVILLE ROAD, TARPON SPRINGS FL 34689
Michael S Urdea	director	100 BUNCE MEADOWS DRIVE, ALAMO CA 94507
Alexander V Lazarev	officer: VP of REsearch and Development	18 WINCHESTER DRIVE, LEXINGTON MA 02420
Edmund Y Ting	officer: Senior VP of Engineering	23642 123RD PLACE SOUTHEAST, KENT WA 48031
Vito J Mangiardi	director	12 POINT GALLINAS ROAD, SAN RAFAEL CA 94903
Jeffrey N Peterson	director	1031 SHORELINE DRIVE, SAN MATEO CA 94404
Mir Conrad F	officer: CFO	19 BRIER LANE, CLIFTON NJ 07012
Clayton A Struve	10 percent owner	175 W JACKSON BLVD, SUITE 440, CHICAGO IL 60604
Css Llc/il	other: (a)	175 WEST JACKSON BLVD, SUITE 440, CHICAGO IL 60604
R Wayne Fritzsche	director	835 GREENS PARKWAY, SUITE 150, HOUSTON TX 77067